Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “labelled”
Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT01560585. IPD Sharing: NO. Countries: 1. Publications: 1.
Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)
ClinicalTrials.gov study NCT02537431. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Open-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
ClinicalTrials.gov study NCT00505934. IPD Sharing: Not stated. Countries: 6. Publications: 1.
An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
ClinicalTrials.gov study NCT02189252. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With No
ClinicalTrials.gov study NCT01493557. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Open-label Extension Study Of RN624
ClinicalTrials.gov study NCT00399490. IPD Sharing: YES. Countries: 1. Publications: 1.
A Phase II, Multi-Center, Open-Label, Uncontrolled Study to Evaluate the Efficacy and Safety of Sorafenib Given Daily in Combination With Repeated 21-Day Cycles of Dacarbazine (DTIC) Chemotherapy in S
ClinicalTrials.gov study NCT00492297. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase II AZD9291 Open Label Study in NSCLC After Previous EGFR TKI Therapy in EGFR and T790M Mutation Positive Tumours
ClinicalTrials.gov study NCT02094261. IPD Sharing: YES. Countries: 8. Publications: 5.
Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects
ClinicalTrials.gov study NCT03092375. IPD Sharing: NO. Countries: 1. Publications: 2.
An Open-Label Pharmacokinetics and Safety Study of Talazoparib
ClinicalTrials.gov study NCT02997163. IPD Sharing: NO. Countries: 2. Publications: 1.
Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human
ClinicalTrials.gov study NCT03639311. IPD Sharing: YES. Countries: 2. Publications: 2.
Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy
ClinicalTrials.gov study NCT01364597. IPD Sharing: Not stated. Countries: 12. Publications: 3.
Open-label, Randomized Trial in Participants Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH
ClinicalTrials.gov study NCT01651780. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis
ClinicalTrials.gov study NCT00678470. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS
ClinicalTrials.gov study NCT00844844. IPD Sharing: Not stated. Countries: 5. Publications: 2.
An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)
ClinicalTrials.gov study NCT02041533. IPD Sharing: Not stated. Countries: 26. Publications: 2.
GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate Cancer
ClinicalTrials.gov study NCT01176513. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD
ClinicalTrials.gov study NCT03282123. IPD Sharing: NO. Countries: 1. Publications: 1.
AR101 Real-World Open-Label Extension Study
ClinicalTrials.gov study NCT03337542. IPD Sharing: NO. Countries: 2. Publications: 1.
An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women
ClinicalTrials.gov study NCT01796301. IPD Sharing: Not stated. Countries: 11. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.